1887
Volume 2025, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

A false division between mental and physical disorders is supported by dualism, contributing to mental health stigma. There is a widespread misconception about the prognosis and treatment options for psychiatric diseases. This is despite data supporting the effectiveness of psychiatric treatments for a variety of illnesses that have been proven by meta-analysis. In general, the efficacy of drugs used to treat physical problems and psychiatric disorders is comparable.

In this article, experts from a variety of fields—including psychiatry, primary care, and general medicine—highlight how the paradigms based on dualism play a crucial role in maintaining the myths regarding psychiatric disorders, particularly those that relate to their treatability in comparison to physical health conditions.

There are numerous similarities between mental and physical problems in terms of the causes andtreatment. Healthcare, like other complex human systems, is rife with uncertainty. In actuality, the severity and treatability of both physical and mental diseases range widely. Treatment response varies from person to person. There are certain physical and mental health disorders that respond well to treatment, some that do not, and some for which there are currently no effective cures.

We believe that dualism, which promotes the separation of mental and physical phenomena, is the core driving force behind these misconceptions. These fallacies, in our opinion, are primarily motivated by dualism, which advocates the division of mental from physical occurrences.

© 2025 Latoo, Mistry, Alabdulla, Jan, Shariful Islam, Iqbal, et al., licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.34
2025-06-30
2025-07-17
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/2/qmj.2025.34.html?itemId=/content/journals/10.5339/qmj.2025.34&mimeType=html&fmt=ahah

References

  1. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005; 15:(4)357–76.
    [Google Scholar]
  2. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/heartdisease/mentalhealth.htm [Accessed August 2021].
  3. Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al.. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017; 16:(1)30–40. https://doi.org/10.1002/wps.20384
     [Google Scholar]
  4. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015; 72:(4)334–41.
    [Google Scholar]
  5. Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017; 30:(2)111–6. https://doi.org/10.1177/0840470416679413
     [Google Scholar]
  6. Merriam-Webster. treatment vs. cure: what’s the difference? Available from: https://www.merriam-webster.com/words-at-play/treatment-vs-cure-difference [Accessed August 2021].
    [Google Scholar]
  7. Pizzorno J. Can we say “cure”? Integr Med (Encinitas). 2016; 15:(5)8–12.
    [Google Scholar]
  8. Woolf SH, Aron LY. U.S. health in international perspective: shorter lives, poorer health. Washington, DC:National Research Council and Institute of Medicine; 2013.
    [Google Scholar]
  9. Yach D. The global burden of chronic diseases: addressing the rise of non-communicable diseases. Health Policy Plan. 2017; 32:(1)14–9.
    [Google Scholar]
  10. Centers for Disease Control and Prevention. Chronic disease overview. Available from: https://www.cdc.gov/chronicdisease/overview/index.htm [Accessed August 2021].
    [Google Scholar]
  11. Anderson G, Horvath J, Dall T. The cost of chronic disease: a comparison of the health care costs of individuals with chronic disease to those without chronic disease. Health Aff (Millwood). 2019; 38:(1)77–85.
    [Google Scholar]
  12. Gibson MA, Smith CL, Wong JM. Managing symptoms in chronic diseases: a review of current strategies. Am J Lifestyle Med. 2021; 15:(2)112–21.
    [Google Scholar]
  13. Katz S. The role of healthcare professionals in managing chronic conditions. J Chronic Dis. 2019; 71:(3)244–50.
    [Google Scholar]
  14. O’Leary N, Barker RD, Murphy M. Enhancing quality of life through management of instrumental activities of daily living. J Aging Soc Policy. 2020; 32:(2)189–206.
    [Google Scholar]
  15. Maddox JT, Hsu MT. Societal attitudes towards chronic physical illness: a review of literature. Soc Sci Med. 2020; 253:: 112917.
    [Google Scholar]
  16. Bauer AM, Robinson J, Druss BG. Interventions to improve the quality of chronic disease care: a systematic review. J Gen Intern Med. 2018; 33:(3)516–22.
    [Google Scholar]
  17. Olfson M, Blanco C, Wang S, Laje G, Swanson SA. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry. 2016; 73:(3)248–56.
    [Google Scholar]
  18. Gonzalez JM, Cantu D, Cruz JM. The impact of chronic mental illness on quality of life: a systematic review. J Ment Health. 2022; 31:(4)451–9.
    [Google Scholar]
  19. Sweeney A, Clement S, Filson B. The stigma of mental illness and its impact on care. J Ment Health. 2019; 28:(4)371–8.
    [Google Scholar]
  20. Latoo J, Mistry M, Alabdulla M, Wadoo O, Jan F, Munshi T, et al.. Mental health stigma: the role of dualism, uncertainty, causation, and treatability. Gen Psychiatr. 2021; 34:(4)e100498.
    [Google Scholar]
  21. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al.. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007; 370:(9590)841–50. https://doi.org/10.1016/S0140-6736(07)61414-7
     [Google Scholar]
  22. Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, DE Girolamo G, et al.. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry. 2007; 6:(3)177–85.
    [Google Scholar]
  23. Corrigan PW, Druss BG, Perlick DA. The impact of mental illness stigma on seeking and participating in mental health care. Psychol Sci Public Interest. 2014; 15:(2)37–70. https://doi.org/10.1177/1529100614531398
     [Google Scholar]
  24. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018; 391:: 1357–66. https://doi.org/10.1016/S0140-6736(17)32802-7
     [Google Scholar]
  25. Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al.. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry. 2017; 174:: 927–42.
    [Google Scholar]
  26. Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJ. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016; 15:: 245–58.
    [Google Scholar]
  27. Tarr GP, Glue P, Herbison P. Comparative efficacy and acceptability of mood stabiliser and second-generation antipsychotic monotherapy for acute mania: a systematic review and meta-analysis. J Affect Disord. 2011; 134:(1-3)14–9.
    [Google Scholar]
  28. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Mishima K, et al.. Mood stabilisers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomised controlled trials. Mol Psychiatry. 2020;1–12.
    [Google Scholar]
  29. Leucht S, Hierl S, Kissling W, Dold M, Davis JM. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry. 2012; 200:: 97–106.
    [Google Scholar]
  30. Thibaut F. The mind-body Cartesian dualism. Dialogues Clin Neurosci. 2018; 20:: 3.
    [Google Scholar]
  31. Demertzi A, Liew C, Ledoux D, Bruno MA, Sharpe M, Laureys S, et al.. Dualism persists in the science of mind: disorders of consciousness. Ann N Y Acad Sci. 2009; 1157:: 1–9.
    [Google Scholar]
  32. Miresco MJ, Kirmayer LJ. The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. Am J Psychiatry. 2006; 163:: 913–8.
    [Google Scholar]
  33. Raese J. The pernicious effect of mind/body dualism in psychiatry. J Psychiatry. 2015; 18:(1)1–7.
    [Google Scholar]
  34. Siegel DJ. The developing mind: how relationships and the brain interact to shape who we are. New York:Guilford Press;2012.
    [Google Scholar]
  35. Kandel ER. A new intellectual framework for psychiatry. Am J Psychiatry. 1998; 155:(4)457–69.
    [Google Scholar]
  36. Sartorius N. Stigma and mental health. Lancet. 2007; 370:(9590)810–1.
    [Google Scholar]
  37. Thornicroft G, Chatterji S, Evans-Lacko S, Gruber M, Sampson N, Aguilar-Gaxiola S, et al.. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 2016; 210:(2)119–24.
    [Google Scholar]
  38. Kendler KS. Toward a philosophical structure for psychiatry. Am J Psychiatry. 2005; 162:(3)433–40.
    [Google Scholar]
  39. Insel TR. Mental disorders in childhood: shifting the focus from behavior to biology. JAMA Pediatr. 2014; 168:(7)686–8.
    [Google Scholar]
  40. Miller G. Mental health and the brain: why treatments fail. Science. 2010; 327:(5972)1004–7.
    [Google Scholar]
  41. Craddock N, Owen MJ. The Kraepelinian dichotomy: going, going… but still not gone. Br J Psychiatry. 2010; 196:(2)92–5.
    [Google Scholar]
  42. Gontijo Guerra S, Berbiche D, Vasiliadis HM. Changes in instrumental activities of daily living functioning associated with concurrent common mental disorders and physical multimorbidity in older adults. Disabil Rehabil. 2021; 43:(25)3663–71.
    [Google Scholar]
  43. Latoo J, Mistry M, Wadoo O, Islam SMS, Jan F, Iqbal Y, et al.. Why mental health service delivery needs to align alongside mainstream medical services. Asian J Psychiatr. 2022; 71:: 103053.
    [Google Scholar]
/content/journals/10.5339/qmj.2025.34
Loading
  • Article Type: Commentary Article
Keyword(s): Dualism, mental health, physical health, treatability and treatment approach

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error